Mobile Phones
This presentation is the property of its rightful owner.
Sponsored Links
1 / 7

Fourth International Conference PowerPoint PPT Presentation


  • 90 Views
  • Uploaded on
  • Presentation posted in: General

Mobile Phones. - Is There A Health Risk?. Fourth International Conference. 9th - 10th November 1999, London. Mobile Phones. - Is There A Health Risk?. Day 1: Current Status of Scientific Knowledge Chairman:Gerd Friedrich, Managing Director Forschungsgemeinschaft Funk, Germany. Session1.

Download Presentation

Fourth International Conference

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Fourth international conference

Mobile Phones

- Is There A Health Risk?

Fourth International Conference

9th - 10th November 1999, London


Fourth international conference

Mobile Phones

- Is There A Health Risk?

Day 1: Current Status of Scientific Knowledge

Chairman:Gerd Friedrich, Managing Director

Forschungsgemeinschaft Funk, Germany

Session1.

Biological Effects of RF Radiation

Session2.

Dosimetry and Standards

Session3.

The Research Agenda

Session4.

The Role of the Media


Fourth international conference

Mobile Phones

- Is There A Health Risk?

Session1.

Biological Effects of RF Radiation

Biological Effects of Radiofrequency Radiation

James Lin, Professor of Bioengineering, University of Illinois, USA

Epidemiological Studies

Patricia Mckinney, University of Leeds, UK

Cancer-Related Animal Studies

Päivi Heikkinen, Department of Environmental Sciences, University of Kuopio, Finland

Provocation and Behaviour Studies

Zenon Sienkiewicz, National Radiological Protection Board, UK

Human Physiological and Cognitive Studies

Alan Preece, Department of Medical Physics, University of Bristol, UK

In-Vitro Studies

Isabelle Lagroye, Assistant Professor, Bioelectromagnetics Laboratory, University of Bordeaux, France


Fourth international conference

Mobile Phones

- Is There A Health Risk?

Session2.

Dosimetry and Standards

Determination of RF Exposure Levels From Handsets

Joe Wiart, France Telekom CNET, France

Determination of RF Exposure Levels from Basestations

György Thuróczy, National Research Institute for Radiobiology and Radiohygiene, Hungary

Standards and Compliance Testing

Paolo Bernardi, Department of Electrical Engineering, University of Rome „La Sapienza“, Italy

Thermal and RF Modelling of Cellular Phones

Jan Lagendijk, Head of Radiation Oncology Physics, University Medical Centre Utrecht, Holland


Fourth international conference

Mobile Phones

- Is There A Health Risk?

Session3.

The Research Agenda

Priorities and Co-ordination for 2003 and 2004 Evaluations

Anthony Muc, World Health Organization, Switzerland

Research topics in the Fifth Framework Programme

Arne Wennberg, Chairman, National Institute for Working Life, Sweden,

Chairman, COST244bis Project

Interpreting the Science

Sheila Johnston, PhD Experimental Psychology & Neuroscience, UK

Video - Its in the Air


Fourth international conference

Mobile Phones

- Is There A Health Risk?

Session4.

The Role of the Media

- Panel Session -

Moderator:Paul Jackson, Editor, Microwave Engineering Europe, UK

Panellists:Tom Wills-Sandford, FEI, UK

Stephen McClelland, Editor, Telecommunications International, UK

Nic Fleming, Reporter, Daily Express, UK

Simon Best, Editor, Electromagnetic Hazard and Therapy, UK

Michaela Reeh, FMK, Austria


Fourth international conference

International WHO EMF Project

Guidelines for Quality EMF Research

  • The project should test a clearly defined hypothesis

  • The biological system used should be appropriate to the end-point(s) studied

  • Only well-characterized biological systems or assays should be used

  • The number of tests in an experiment should be sufficient to detect reliably the expected size of the effect

  • A protocol, consistent with Good Laboratory Practice (GLP) guidelines should be established and documented (including symmetric handling of specimens, appropriate controls, blind-study guidelines)

  • Quality assurance (QA) procedures including dosimetry and monitoring of the programme by an independent group are required


  • Login